An AI Voice Agent Can Deliver Talk Therapy to Medicare Patients Before the FDA Evaluates Its Effectiveness

An AI voice agent is being used to deliver talk therapy services to Medicare patients ahead of FDA evaluation of its effectiveness. The development raises questions about regulatory oversight of AI-powered mental health interventions. The deployment occurs as the healthcare system faces growing demand for mental health services and limitations in therapist availability. Regulatory pathways for AI-based therapeutics remain under development, with the FDA currently assessing how such technologies should be classified and monitored for safety and efficacy in clinical settings.